Systemic Lupus Erythematosus Flashcards

1
Q

what is SLE?

A

rare disease and is part of a family of overlapping chronic autoimmune diseases

shows type 3 hypersensitivity (immune complexes) and type 2 (antibodies against RBC, WBC, platelets leading to pancytopenia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

examples of autoimmune diseases in the family that SLE is part of?

A

RA
Sjogren’s syndrome
dermatomyositis, polymyositis
systemic sclerosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

who does SLE affect mostly?

A

female (9:1)
15-40 years
Afro-carribean, Far East Asian, Asian

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what does SLE primarily affect?

A

joints and skin and kidenys

– also affects lungs and has unique haematology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the genetic associations of SLE?

A
  • Multiple genes: Fc receptors, IRF5, CTLA4, MHC class 2 HLA genes (DR3)
  • Complement deficiency: C1q and C3.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the (general) presentation of SLE?

A
Malaise
fatigue
fever
weight loss
lymphadenopathy (lymphomas excluded).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are specific features of SLE?

A

Butterfly rash
alopecia
arthralgia
Raynaud’s phenomenon.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are some severe presentations of SLE?

A

o Inflammation of the kidney, CNS, heart & lungs.
o Accelerated atherosclerosis.
o Vasculitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the cause of autoantigens production in SLE?

A

there is impaired clearance associated with inflammation of apoptotic bodies. They linger in the body and expose nuclear antigens which then generate autoantigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the main driver of SLE?

A

immune complexes

these bind to endothelial cell to cause local inflammation and activate enzymes after complement activation to cause cell apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what causes the formation of immune complexes?

A
  • dendritic cells take up autoantigens
  • overactive B cells exposed to auto antigens (and activated)
  • plasma cells form IgG autoantibodies that form immune complexes (ab-ag)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the effect of immune complexes?

A

deposit in tissues (kidneys/skin mainly) and then activates complement in the tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

summary of auto-antibody formation summary

A
  1. Abnormal clearance of apoptotic bodies.
  2. Dendrites take up autoantigens –>b-cell activation.
  3. B-cell Ig-class switch and affinity maturation.
  4. IgG-autoantibodies.
  5. Immune complexes.
  6. Complement activation via classical pathway.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how can SLE be tested for in the lab?

A

check for

  • antinuclear antibodies
  • anti dsDNA antibodies

if ANAs present, they will bind to the cell’s nuclear antigens
fluorescently labelled AB is added that binds to ANAs and you observe the pattern of attachment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what other tests can used?

A
anti-dsDNA and Sm (more specific) 
anti-Ro and/or La
increased complement consumption 
normocytic anaemia 
haematology and renal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

why might complement consumption be measured to check activity of SLE?

A

patients with active lupus will have more complement bound to immune complexes and so the blood complement will be LOW in active lupus

17
Q

why may SLE patients present with autoimmune haemolytic anaemia?

A

ABs bind to RBC surfaces and they are extravascularly removed in the spleen.

18
Q

how is the severity of SLE assessed?

A
  1. Identify pattern of organ involvement.
  2. Monitor function of affected organs:
    a. Renal
    – BP, U&E, urine sediment GFR.
    b. Lungs/CVS
    – lung function tests, echocardiography.
  3. Identify the patterns of autoantibodies expressed.
    a. Anti-dsDNA, anti-Sm
    – high levels of these ABs can predict renal disease.
    b. Anti-cardiolipin antibodies.
19
Q

what will happen to the erythrocyte sedimentation rate in disease that is become severe?

A

increase

20
Q

what is importance of picking up symptoms early?

A

so less damage to organs systems occur

21
Q

in what stage of disease severity is there organ involvement?

A

moderate to severe

mild has no organ involvement

22
Q

what is the treatment for mild SLE?

A

 Paracetamol ± NSAIDs.
 Hydroxychloroquine (for the rash)
 Topical corticosteroids.

23
Q

what are the severities of SLE and what is involved in each?

A

mild–> joint +/- skin

moderate–> inflammation of organs, pleuritis, pericarditis

severe–> severe inflammation of vital organs

24
Q

what is the treatment for moderate SLE?

A

 Hydroxychloroquine and NSAIDs will stop working in moderate disease.

Switch from topic to oral glucocorticoids
High dose and titrate down

25
Q

why is a high dose given for moderate SLE? what can be done instead?

A

o High dose needed to supress disease activity but also is very toxic so can give the corticosteroids with steroid-sparing agents to lower the dose required.

26
Q

what are the 2 drugs given in severe SLE?

A

 Azathioprine – a steroid-sparing drug
Cyclophosphamide – only used in SEVERE organ involvement

  • mycophenolate mofetil
  • rituximab
27
Q

what is the side effect of Azathioprine?

A

risk of neutropenia and bone marrow suppression so requires blood monitoring.

28
Q

what is the side effect of Cyclophosphamide?

A

infertility

29
Q

why is azathioprine a favourable option?

A

safe during pregnancy as it is steroid sparing

30
Q

what is the prognosis of SLE?

A

15 year survival
o No nephritis = 85%.
o Nephritis = 60%.

31
Q

when is prognosis worse?

A

black, male, low socio-economic background/status.

32
Q

what are the two peaks in SLE mortality?

A

o Early death – renal failure, CNS disease, infection.

o Late death – MI, stroke.

33
Q

what can be seen on a blood film in SLE?

A

 Shistocytes.
 Spherocytes.
 Tear drop cells.
 Few – leukocytes and platelets

34
Q

what can be seen in renal biopsy in SLE?

A

 Hyper-cellular – more cells than normal.
 Mesangial proliferation.
 Crescent development – inflammatory cells that have migrated into the glomerulus.
 Rapidly proliferating glomerulonephritis.

35
Q

which antibody in SLE is specific to the disease?

A

anti dsDNA antibodies

36
Q

which antibody is less specific to the disease?

A

anti-nuclear antibodies

37
Q

which HLA defect leads to SLE?

A

HLA DR3